Alphatec Holdings (ATEC) Stock Forecast & Price Target

Compare

946 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

ATEC Analyst Ratings

Strong Buy

8 Buy

2 Hold

0 Sell

Based on 10 analysts giving stock ratings to

Alphatec

Holdings

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

ATEC Stock 12 Month Forecast

Average Price Target

$24.33

▲(64.08% Upside)

Based on 10 Wall Street analysts offering 12 month price targets for Alphatec Holdings in the last 3 months. The average price target is $24.33 with a high forecast of $28.00 and a low forecast of $20.00. The average price target represents a 64.08% change from the last price of $14.83.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"9":"$9","14":"$14","19":"$19","24":"$24","29":"$29"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":28,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$28.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":24.333333333333332,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$24.33</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":20,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$20.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[9,14,19,24,29],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2025","6":"Aug<br/>2025","9":"Nov<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,14.83,15.843076923076923,16.856153846153845,17.869230769230768,18.88230769230769,19.895384615384614,20.908461538461538,21.92153846153846,22.934615384615384,23.947692307692307,24.96076923076923,25.973846153846154,26.986923076923077,{"y":28,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,14.83,15.56102564102564,16.292051282051283,17.02307692307692,17.754102564102563,18.485128205128206,19.216153846153844,19.947179487179486,20.67820512820513,21.409230769230767,22.14025641025641,22.87128205128205,23.60230769230769,{"y":24.333333333333332,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,14.83,15.227692307692308,15.625384615384615,16.02307692307692,16.42076923076923,16.818461538461538,17.216153846153844,17.613846153846154,18.01153846153846,18.40923076923077,18.806923076923077,19.204615384615384,19.60230769230769,{"y":20,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":11.79,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.53,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.08,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.06,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.3,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.93,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.77,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.68,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.97,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.99,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.96,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.04,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.83,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$28.00

Average Price Target$24.33

Lowest Price Target$20.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Caitlin Roberts

Canaccord Genuity

$25

Buy

68.58%

Upside

Reiterated

02/02/26

Analysts Offer Insights on Healthcare Companies: Alphatec Holdings (NASDAQ: ATEC), Viridian Therapeutics (NASDAQ: VRDN) and Enovis (NYSE: ENOV)

Mathew Blackman

TD Cowen

$27→$20

Buy

34.86%

Upside

Reiterated

01/27/26

Alphatec: Procedure-Focused Spine Innovation and Enabling Technologies Support Profitable Growth and Multiple Expansion Upside

Ben Haynor

Lake Street

$25

Buy

68.58%

Upside

Reiterated

01/20/26

Lake Street Keeps Their Buy Rating on Alphatec Holdings (ATEC)

Vik Chopra

Wells Fargo

$28

Buy

88.81%

Upside

Reiterated

01/13/26

Alphatec Holdings (ATEC) Gets a Buy from Wells Fargo

Matt Miksic

Barclays

$27

Buy

82.06%

Upside

Reiterated

01/12/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Alphatec Holdings (NASDAQ: ATEC), Biohaven Ltd. (NYSE: BHVN) and Syndax Pharmaceuticals (NASDAQ: SNDX)

David Saxon

Needham

$22

Buy

48.35%

Upside

Reiterated

01/12/26

Alphatec: Conservative 2026 Guide, Strong 2025 Momentum and Strategic Optionality Support Buy Rating After Pullback

Sean Lee CFA

H.C. Wainwright

$24

Buy

61.83%

Upside

Reiterated

01/12/26

Alphatec: Strong Operational Momentum and 2026 Growth Outlook Support Buy Rating and $24 Target

Thomas Stephan

Stifel Nicolaus

Hold

―

Reiterated

01/07/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Alphatec Holdings (NASDAQ: ATEC) and EyePoint Pharmaceuticals (NASDAQ: EYPT)

Keith Hinton

Freedom Capital Markets

$25

Buy

68.58%

Upside

Initiated

12/10/25

Alphatec Holdings (ATEC) Receives a New Rating from Freedom Capital Markets

Patrick Wood

Morgan Stanley

$21→$23

Hold

55.09%

Upside

Reiterated

12/02/25

Alphatec price target raised to $23 from $21 at Morgan StanleyAlphatec price target raised to $23 from $21 at Morgan Stanley

Matthew O'Brien

Piper Sandler

$20→$25

Buy

68.58%

Upside

Reiterated

10/31/25

Alphatec price target raised to $25 from $20 at Piper SandlerAlphatec price target raised to $25 from $20 at Piper Sandler

Allen Gong

J.P. Morgan

$19

Buy

28.12%

Upside

Initiated

10/24/25

Alphatec Holdings: Pioneering Growth in the Spine Market with Innovative Technologies and Strategic Acquisitions

Jason Wittes

Roth MKM

$22

Buy

48.35%

Upside

Reiterated

08/01/25

Analysts Are Bullish on Top Healthcare Stocks: Alphatec Holdings (ATEC), Orchestra BioMed Holdings (OBIO)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Caitlin Roberts

Canaccord Genuity

$25

Buy

68.58%

Upside

Reiterated

02/02/26

Analysts Offer Insights on Healthcare Companies: Alphatec Holdings (NASDAQ: ATEC), Viridian Therapeutics (NASDAQ: VRDN) and Enovis (NYSE: ENOV)

Mathew Blackman

TD Cowen

$27→$20

Buy

34.86%

Upside

Reiterated

01/27/26

Alphatec: Procedure-Focused Spine Innovation and Enabling Technologies Support Profitable Growth and Multiple Expansion Upside

Ben Haynor

Lake Street

$25

Buy

68.58%

Upside

Reiterated

01/20/26

Lake Street Keeps Their Buy Rating on Alphatec Holdings (ATEC)

Vik Chopra

Wells Fargo

$28

Buy

88.81%

Upside

Reiterated

01/13/26

Alphatec Holdings (ATEC) Gets a Buy from Wells Fargo

Matt Miksic

Barclays

$27

Buy

82.06%

Upside

Reiterated

01/12/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Alphatec Holdings (NASDAQ: ATEC), Biohaven Ltd. (NYSE: BHVN) and Syndax Pharmaceuticals (NASDAQ: SNDX)

David Saxon

Needham

$22

Buy

48.35%

Upside

Reiterated

01/12/26

Alphatec: Conservative 2026 Guide, Strong 2025 Momentum and Strategic Optionality Support Buy Rating After Pullback

Sean Lee CFA

H.C. Wainwright

$24

Buy

61.83%

Upside

Reiterated

01/12/26

Alphatec: Strong Operational Momentum and 2026 Growth Outlook Support Buy Rating and $24 Target

Thomas Stephan

Stifel Nicolaus

Hold

―

Reiterated

01/07/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Alphatec Holdings (NASDAQ: ATEC) and EyePoint Pharmaceuticals (NASDAQ: EYPT)

Keith Hinton

Freedom Capital Markets

$25

Buy

68.58%

Upside

Initiated

12/10/25

Alphatec Holdings (ATEC) Receives a New Rating from Freedom Capital Markets

Patrick Wood

Morgan Stanley

$21→$23

Hold

55.09%

Upside

Reiterated

12/02/25

Alphatec price target raised to $23 from $21 at Morgan StanleyAlphatec price target raised to $23 from $21 at Morgan Stanley

Matthew O'Brien

Piper Sandler

$20→$25

Buy

68.58%

Upside

Reiterated

10/31/25

Alphatec price target raised to $25 from $20 at Piper SandlerAlphatec price target raised to $25 from $20 at Piper Sandler

Allen Gong

J.P. Morgan

$19

Buy

28.12%

Upside

Initiated

10/24/25

Alphatec Holdings: Pioneering Growth in the Spine Market with Innovative Technologies and Strategic Acquisitions

Jason Wittes

Roth MKM

$22

Buy

48.35%

Upside

Reiterated

08/01/25

Analysts Are Bullish on Top Healthcare Stocks: Alphatec Holdings (ATEC), Orchestra BioMed Holdings (OBIO)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Alphatec Holdings

3 Months

xxx

Success Rate

11/17 ratings generated profit

Average Return

+16.68%

reiterated a xxx

rating 6 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 64.71% of your transactions generating a profit, with an average return of +16.68% per trade.

1 Year

Mathew BlackmanTD Cowen

Success Rate

11/16 ratings generated profit

Average Return

+23.52%

reiterated a buy rating 9 months ago

Copying Mathew Blackman's trades and holding each position for 1 Year would result in 68.75% of your transactions generating a profit, with an average return of +23.52% per trade.

2 Years

xxx

Success Rate

12/16 ratings generated profit

Average Return

+13.01%

reiterated a xxx

rating 6 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 75.00% of your transactions generating a profit, with an average return of +13.01% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ATEC Analyst Recommendation Trends

Rating

Oct 25

Nov 25

Dec 25

Jan 26

Feb 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, ATEC has received 14 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. ATEC average Analyst price target in the past 3 months is 24.33.

Each month's total comprises the sum of three months' worth of ratings.

ATEC Financial Forecast

ATEC Earnings Forecast

Next quarter’s earnings estimate for ATEC is $0.04 with a range of -$0.01 to $0.07. The previous quarter’s EPS was $0.03. ATEC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year ATEC has Performed in-line its overall industry.

ATEC Sales Forecast

Next quarter’s sales forecast for ATEC is $211.25M with a range of $208.50M to $212.80M. The previous quarter’s sales results were $196.50M. ATEC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.06% of the time in the same period. In the last calendar year ATEC has Performed in-line its overall industry.

ATEC Stock Forecast FAQ

What is ATEC’s average 12-month price target, according to analysts?

Based on analyst ratings, Alphatec Holdings’s 12-month average price target is 24.33.

What is ATEC’s upside potential, based on the analysts’ average price target?

Alphatec Holdings has 64.08% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is ATEC a Buy, Sell or Hold?

Alphatec Holdings has a consensus rating of Strong Buy which is based on 8 buy ratings, 2 hold ratings and 0 sell ratings.

What is Alphatec Holdings’s price target?

The average price target for Alphatec Holdings is 24.33. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $28.00 ,the lowest forecast is $20.00. The average price target represents 64.08% Increase from the current price of $14.83.

What do analysts say about Alphatec Holdings?

Alphatec Holdings’s analyst rating consensus is a Strong Buy. This is based on the ratings of 10 Wall Streets Analysts.

How can I buy shares of ATEC?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Alphatec Holdings (ATEC) Stock Forecast & Price Target

ATEC Analyst Ratings

ATEC Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Alphatec Holdings

ATEC Analyst Recommendation Trends

ATEC Financial Forecast

ATEC Earnings Forecast

ATEC Sales Forecast

ATEC Stock Forecast FAQ

Detailed List of Analyst Forecasts